Haven Headache & Migraine Center Becomes a CEFALY Premier Partner Clinic

DARIEN, Conn., Aug. 13, 2025 /PRNewswire/ -- CEFALY Technology, the maker of FDA-cleared migraine treatment devices, today announced that Haven Headache & Migraine Center has joined the CEFALY Clinician Referral & Certification Program as a Premier Partner Clinic.

This initiative equips healthcare providers with tools and education to offer clinically proven, drug-free treatments for migraine. All of Haven's clinicians have completed advanced training in CEFALY's neuromodulation protocols, reflecting the practice's commitment to evidence-based, personalized care.

Haven Headache & Migraine Center delivers rapid access to headache specialists through its virtual-first model and currently serves patients across California. Haven was founded by Izac Ross, a lifelong migraine patient, and designed by nationally recognized headache experts: Founder and Chief Medical Officer Dr. Nada Hindiyeh, UCNS, and Clinical Director Dr. Susan Hutchinson, UNCS. Haven focuses on reducing time to relief through comprehensive care plans that include medication, lifestyle changes, procedures, and now, neuromodulation. Its unique program combines a connected headache diary that enables continuous care, clear, easy-to-read care plans, and multimodal approaches including pain psychology.

As a Premier Partner, Haven appears in CEFALY's Find a Provider directory, helping more patients access clinicians trained in this non-invasive, wearable treatment.

"CEFALY and Haven both believe patients deserve more than a prescription," said Jen Trainor-McDermott, CEO of CEFALY Technology. "Haven's model delivers the speed, empathy, and expertise that so many people with migraine have struggled to find."

The CEFALY device is based on more than 20 years of research and offers both acute and preventive treatment for migraine attacks. It stimulates the trigeminal nerve through gentle electrical impulses, reducing migraine pain without medication side effects.

"We're proud to collaborate with Haven's team to bring this powerful, non-pharmacologic option to more people living with migraine," added Trainor-McDermott.

The CEFALY Clinician Referral & Certification Program is open to clinical practices in the United States and Canada that treat patients with migraine, including primary care practices and other specialties. Learn more and enroll here.

About Haven Headache & Migraine Center
Haven is redefining migraine care through fast access, personalized treatment, and ongoing support between visits. Built by people who truly understand migraine, Haven offers virtual-first care from headache specialists, with in-person support for procedures like Botox, nerve blocks, or IV therapy when needed. Haven's model is focused on reducing the burden of migraine, not just writing prescriptions.

Visit www.havenheadache.com to learn more.

About CEFALY Technology
CEFALY Technology is a Belgium-based medical device company with U.S. offices in Darien, Connecticut. Its flagship product, the CEFALY device, is FDA-cleared for the acute and preventive treatment of migraine. Available without a prescription, CEFALY empowers people with migraine to manage their condition through safe, effective, non-invasive neuromodulation.

Learn more at CEFALY.com or follow @CEFALY on social media.

Media Contacts:

CEFALY
Jen Trainor-McDermott
CEO
[email protected]

Haven Headache & Migraine Center
Izac Ross
CEO, Founder & Living with Chronic Migraine
[email protected]

SOURCE CEFALY Technology